Bionpharma Company Profile
What is the competitive landscape for BIONPHARMA
BIONPHARMA has eighty approved drugs.
There are five US patents protecting BIONPHARMA drugs.
Summary for Bionpharma
| US Patents: | 5 |
| Tradenames: | 74 |
| Ingredients: | 69 |
| NDAs: | 80 |
| Patent Litigation for Bionpharma: | See patent lawsuits for Bionpharma |
Drugs and US Patents for Bionpharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 209753-001 | Mar 2, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bionpharma | FLUVOXAMINE MALEATE | fluvoxamine maleate | TABLET;ORAL | 217917-003 | Jan 22, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bionpharma | ETRAVIRINE | etravirine | TABLET;ORAL | 219152-001 | Oct 2, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bionpharma | VALPROIC ACID | valproic acid | CAPSULE;ORAL | 073484-001 | Jun 29, 1993 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bionpharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bionpharma | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | 6,251,426 | ⤷ Start Trial |
| Bionpharma | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 021920-001 | Feb 17, 2006 | 11,090,280 | ⤷ Start Trial |
| Bionpharma | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 021920-001 | Feb 17, 2006 | 9,693,979 | ⤷ Start Trial |
| Bionpharma | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 021920-001 | Feb 17, 2006 | 10,028,925 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bionpharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 101166520 | ⤷ Start Trial |
| Denmark | 1863458 | ⤷ Start Trial |
| Slovenia | 1863458 | ⤷ Start Trial |
| Mexico | 2007011039 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bionpharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0994863 | 07C0037 | France | ⤷ Start Trial | PRODUCT NAME: MODIFICATION CRISTALLINE A DU RUFINAMIDE; REGISTRATION NO/DATE IN FRANCE: EU/1/06/378/001 DU 20070116; REGISTRATION NO/DATE AT EEC: EU/1/06/378/001-016 DU 20070116 |
| 1534313 | 76/2015 | Austria | ⤷ Start Trial | PRODUCT NAME: PHENYLEPHRIN, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND KETOROLAC, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1018 (MITTEILUNG) 20150730 |
| 2498758 | CA 2020 00017 | Denmark | ⤷ Start Trial | PRODUCT NAME: METFORMIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; SAXAGLIPTIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; DAPAGLIFLOZIN ELLER ET FARMACEUTISK ACCEPTABELT SOLVAT DERAF; REG. NO/DATE: EU/1/19/1401 20191113 |
| 1532149 | C300569 | Netherlands | ⤷ Start Trial | PRODUCT NAME: LINAGLIPTINE, DESGEWENST IN DE VORM VAN EEN ZOUT, IN COMBINATIE MET METFORMINEHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/12/780/001-028 20120720 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
